Updated
Spruce BiosciencesSPRB · Healthcare
$46.55+8.99%
Market cap$134M
IndustryBiotechnology
Spruce Biosciences (SPRB) Superinvestor holders
3 of the superinvestors we track hold Spruce Biosciences (SPRB) in their latest 13F filings, $2M in total.
Summary
The largest holder is Steve Cohen (Point72 Asset Management), with $2M, 0.0% of the portfolio.
In their latest quarter: 2 opened a new position.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Steve Cohen Point72 Asset Management |
New position | 28,278 | $2M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
New position | 4,700 | $253,800 | 0.0% | Q2 2026 |
| Didric Cederholm Lion Point Capital |
Held | 1,000 | $54,000 | 0.3% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 3 |
| Q1 2026 | 1 |
| Q4 2025 | 1 |
| Q3 2025 | 1 |
| Q2 2025 | 1 |
| Q1 2025 | 4 |
| Q4 2024 | 4 |
| Q3 2024 | 4 |
Questions about Spruce Biosciences
Which superinvestors own Spruce Biosciences?
3 of the superinvestors we track hold Spruce Biosciences (SPRB) in their latest 13F filings, $2M in total. Steve Cohen, Jim Simons, Didric Cederholm.
Who is the largest superinvestor holder of SPRB?
The largest holder is Steve Cohen (Point72 Asset Management), with $2M, 0.0% of the portfolio.
From Spruce Biosciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.